Skip to main content
See every side of every news story
Published • loading... • Updated

Biodesix Plans 2026 Revenue of $101 Million to $103 Million, About 115 Sales Reps

Summary by TokenPost
Third-quarter total revenue rose 10%, while diagnostic testing revenue increased 16% and test volumes grew 24%. Gross margin was 81%.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

TokenPost broke the news on Sunday, November 8, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal